A study to investigate the safety, tolerability, and pharmacokinetics of AZD7503 in Japanese healthy participants.

Trial Identifier:	D9230C00005
Sponsor:	AstraZeneca
NCTID::	NCT06093542
Start Date:	October 2023
Primary Completion Date:	March 2024
Study Completion Date:	March 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Sumida-ku, JP, 130-0004

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.